Demographics of anti-VEGF procedures in South-West CCGs, 2014/2015; ordered by procedures per patient
CCG Name | % Male | Median age | Procedures per patient (95% CI) | Procedure rate* (95% CI†) | Patient rate* (95% CI) |
NHS Kernow CCG | 43 | 79 | 2.86 (2.75 to 2.97) | 522 (490 to 556) | 172 (191 to 104) |
NHS Dorset CCG | 43 | 82 | 3.32 (3.21 to 3.43) | 419 (394 to 445) | 122 (136 to 74) |
NHS Herefordshire CCG | 38 | 80 | 3.34 (3.14 to 3.53) | 631 (569 to 700) | 175 (210 to 110) |
NHS Somerset CCG | 45 | 78 | 3.48 (3.27 to 3.68) | 304 (276 to 334) | 92 (106 to 57) |
NHS South Warwickshire CCG | 44 | 79 | 3.63 (3.46 to 3.8) | 773 (708 to 844) | 206 (240 to 128) |
NHS Oxfordshire CCG | 40 | 81 | 3.63 (3.5 to 3.76) | 723 (679 to 771) | 197 (220 to 120) |
NHS Northern-Eastern and Western Devon CCG | 41 | 81 | 4.05 (3.95 to 4.16) | 830 (792 to 869) | 201 (218 to 121) |
NHS Newbury and district CCG | 41 | 79 | 4.14 (3.72 to 4.55) | 637 (530 to 764) | 136 (186 to 92) |
NHS Wiltshire CCG | 46 | 79 | 4.17 (3.95 to 4.39) | 459 (419 to 502) | 103 (121 to 64) |
NHS South Devon and Torbay CCG | 40 | 81 | 4.2 (4.05 to 4.35) | 923 (860 to 991) | 206 (235 to 127) |
NHS South Worcestershire CCG | 42 | 79 | 4.36 (4.16 to 4.56) | 875 (806 to 950) | 188 (217 to 116) |
NHS Bath and North-East Somerset CCG | 49 | 81 | 4.44 (4.14 to 4.73) | 735 (650 to 831) | 152 (189 to 97) |
NHS Swindon CCG | 44 | 77 | 4.54 (4.26 to 4.82) | 1034 (928 to 1153) | 216 (260 to 137) |
NHS West Hampshire CCG | 42 | 80 | 5 (4.85 to 5.15) | 1125 (1063 to 1190) | 221 (244 to 133) |
NHS North Somerset CCG | 43 | 80 | 5.43 (5.15 to 5.71) | 1236 (1130 to 1352) | 217 (253 to 135) |
NHS Bristol CCG | 43 | 80 | 5.49 (5.26 to 5.72) | 1346 (1248 to 1451) | 237 (270 to 146) |
NHS Gloucestershire CCG | 42 | 81 | 5.51 (5.33 to 5.68) | 1263 (1194 to 1336) | 226 (249 to 137) |
NHS South Gloucestershire CCG | 46 | 79 | 5.93 (5.65 to 6.22) | 1379 (1264 to 1505) | 222 (258 to 138) |
* Procedure rate and patient rate are the indirectly standardised rates per 100 000 population.
†95% CIs on the procedure rate are calculated using Stukel et al’s method for recurrent outcomes.40
anti-VEGF, antivascular endothelial growth factor; CCG, clinical commissioning group; NHS, National Health Service.